WEST PHARMACEUTICAL SERVICES, INC. Amortization of Intangible Assets
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Amortization of Intangible Assets of $2.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-02-17
- WEST PHARMACEUTICAL SERVICES, INC. amortization of intangible assets for the quarter ending 2022-03-31 was $200.00K, a 0.00% change year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. amortization of intangible assets for the quarter ending 2021-03-31 was $200.00K.
- WEST PHARMACEUTICAL SERVICES, INC. amortization of intangible assets for the quarter ending 2020-06-30 was $200.00K.
- WEST PHARMACEUTICAL SERVICES, INC. amortization of intangible assets for fiscal 2025 was $2.80M, a 22.22% decline from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. amortization of intangible assets for fiscal 2024 was $3.60M, a 0.00% change from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. amortization of intangible assets for fiscal 2023 was $3.60M, a 2.70% decline from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. amortization of intangible assets for fiscal 2022 was $3.70M, a 31.48% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|
| 2025-12-31 | $2.80M 10-K · filed 2026-02-17 | ||
| 2024-12-31 | $3.60M 10-K · filed 2026-02-17 | ||
| 2023-12-31 | $3.60M 10-K · filed 2026-02-17 | ||
| 2022-12-31 | $3.70M 10-K · filed 2025-02-18 | ||
| 2022-03-31 | $200.00K 10-Q · filed 2022-04-28 | ||
| 2021-12-31 | $5.40M 10-K · filed 2024-02-20 | ||
| 2021-03-31 | $200.00K 10-Q · filed 2022-04-28 | ||
| 2020-12-31 | $4.40M 10-K · filed 2023-02-21 | ||
| 2020-06-30 | $200.00K 10-Q · filed 2021-04-30 | $200.00K 10-Q · filed 2020-07-24 | |
| 2019-12-31 | $3.40M 10-K · filed 2022-02-22 | ||
| 2018-12-31 | $2.70M 10-K · filed 2021-02-23 | ||
| 2017-12-31 | $2.40M 10-K · filed 2020-02-24 | ||
| 2016-12-31 | $2.60M 10-K · filed 2019-02-28 | ||
| 2015-12-31 | $3.50M 10-K · filed 2018-02-26 | ||
| 2014-12-31 | $4.90M 10-K · filed 2017-02-28 | ||
| 2013-12-31 | $3.90M 10-K · filed 2016-02-26 | ||
| 2012-12-31 | $3.90M 10-K · filed 2015-02-25 | ||
| 2011-12-31 | $4.30M 10-K · filed 2014-02-27 | ||
| 2010-12-31 | $4.10M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |